Brian Stemme is listed as a director on 9 SEC Form D filings by 2 issuers between Apr 2010 and Jun 2016: AgeneBio, Inc. (Baltimore, MD — biotechnology — 2010–2013; $4.11M reported sold to 27 investors) and Algaeon, Inc. (Indianapolis, IN — biotechnology — 2014–2016; $771K reported sold to 25 investors).
What this means 2 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $4.88M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Brian Stemme and found 8 differences: Brian Stemme appears on 2 deals that stopped filing before reaching their target; 5 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.